Gen-Probe Life Sciences Ltd

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human diseases and screen donated human blood. NATs harness the power of biotechnology to detect diseases more rapidly and/or accurately than older testing methods, and have therefore become one of the fastest-growing segments of the in vitro diagnostics industry.

Gen-Probe markets a broad portfolio of products that use the Company's patented technologies to detect infectious microorganisms, including those causing sexually transmitted diseases (STDs), tuberculosis, strep throat, pneumonia and fungal infections. Gen-Probe's key clinical diagnostics products include the APTIMA COMBO 2® and PACE® assays, which are used to detect the common STDs Chlamydia and gonorrhea.

In blood screening, Gen-Probe developed and manufactures the PROCLEIX® assay, which is used to detect HIV-1 and the hepatitis C virus (HCV) in donated human blood; the PROCLEIX ULTRIO® assay, which detects the hepatitis B virus in addition to HIV-1 and HCV; and the PROCLEIX WNV (West Nile virus) assay. Gen-Probe's blood screening products are marketed worldwide by Chiron, a business unit of Novartis Vaccines and Diagnostics, Inc.

Gen-Probe also has a robust development pipeline. For example, the Company is developing NATs to detect prostate cancer, drug-resistant hospital infections, and human papillomavirus, which causes cervical cancer. In addition, Gen-Probe is working with General Electric and Millipore to develop NATs that detect microorganisms that commonly contaminate industrial processes.

Several of Gen-Probe's current and future molecular diagnostic tests can be performed on the Company's TIGRIS® instrument, the only fully automated, high-throughput NAT system for diagnostics and blood screening.

Gen-Probe is headquartered in San Diego and employs approximately 1,000 people.

Contact Details: Heron House, Oaks Business Park, Crewe Road, Wythenshawe Manchester M23 9HZ United Kingdom Tel: 44 (0)161 946 2200 Fax: 44 (0)161 946 2211 Email: pharmaservices@gen-probe.com WWW: www.gen-probe.com/

Loading...

BioNews Results for Gen-Probe Life Sciences Ltd:
Registration Deadline Extended for the California Healthcare Policy Forum	Yahoo! Canada:  Oct 27 2009 12:30AM Matching: gen probe life sciences

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 777 times since April 2007, the link to the organisation's website has been followed 136 times

Recent Search Terms used to find this page: gen-probe life sciences ltd | gen-probe life sciences ltd | gen probe life sciences ltd web page | gen-probe life sciences ltd | gen probe combo 2 assay | gen-probe life sciences ltd manchester | Gen-Probe Life | gen-probe manchester | gen-probe life sciences limited | Gen-Probe Life Sciences Ltd | .

Search for more companies in Wythenshawe

Search for more companies in Manchester

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Gen-Probe Life Sciences Ltd